Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Hydrophobic anticancer drugs face delivery challenges due to poor solubility and biocompatibility.
• Effective delivery systems are crucial for enhancing therapeutic efficacy and minimizing side effects in cancer therapy.
• Developing targeted, stimuli-responsive nanocarriers is key for advanced drug delivery.

Purpose of the Study:

• To develop a targeted, near-infrared (NIR)-regulated hydrophobic drug delivery platform.
• To integrate chemotherapy and photothermal therapy for synergistic anticancer effects.
• To evaluate the therapeutic efficacy and safety of a camptothecin-loaded nanocarrier system.

Main Methods:

• Fabrication of gold nanorods within a mesoporous silica framework (AuMPs).
• Functionalization of AuMPs with polyethylene glycol and folic acid for targeted delivery.
• Utilizing NIR light-induced photothermal effect for controlled drug release.
• In vitro and in vivo evaluation of the camptothecin-loaded nanocarrier's therapeutic effects.

Main Results:

• The developed AuMP nanocarrier demonstrated efficient loading and controlled release of hydrophobic drugs upon NIR irradiation.
• Synergistic therapeutic effects were observed both in vitro and in vivo, enhancing anticancer activity.
• The targeted delivery system showed high spatial and temporal resolution for remote-controlled drug release.
• Reduced drug side effects were noted due to the targeted and controlled release mechanism.

Conclusions:

• The NIR-regulated, targeted drug delivery platform offers a promising solution for hydrophobic anticancer drugs.
• This integrated chemo-photothermal therapy approach enhances treatment efficacy and patient safety.
• The developed nanocarrier system holds significant potential for future clinical applications in cancer therapy.